[Skip to Navigation]
Comment & Response
January 2014

Failure to Report Financial Disclosure Information

Author Affiliations
  • 1Center for Health Statistics, Departments of Medicine and Health Studies, University of Chicago, Chicago, Illinois
  • 2Department of Psychology, University of Minnesota, Minneapolis
  • 3Western Psychiatric Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
JAMA Psychiatry. 2014;71(1):95. doi:10.1001/jamapsychiatry.2013.3888

To the Editor We apologize to the editors and readers of JAMA Psychiatry for our failure to fully disclose our financial interests in an article1 that reported a diagnostic tool, the Computerized Adaptive Test for Depression (CAT-DI). Following acceptance of the paper, we disclosed that “The CAT-DI will ultimately be made available for routine administration, and its development as a commercial product is under consideration.” The company that owns the rights to CAT-DI and several related tests is Psychiatric Assessments, Inc (PAI), which uses the trade name of Adaptive Testing Technologies (ATT) on a website describing these tests.